Showing 1‐10 of 500
Corporate
03 Oct 2024
Lonza Nominates David Meline as Independent Board Member
David Meline brings extensive governance, financial and industry experience to Lonza’s Board of Directors Olivier Verscheure will not stand for re-election at the 2025 Annual...
Biologics
01 Oct 2024
Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
The Vacaville site is one of the largest biologics manufacturing facilities in the world Acquisition extends Lonza’s US Biologics footprint with a significant presence on the...
Cell & Gene
24 Sep 2024
Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
Lonza to manufacture CASGEVY®, the world’s first CRISPR/Cas9 gene-edited cell therapy, for global commercial supply CASGEVY® will be manufactured at Lonza’s Geleen (NL) cell...
Corporate
28 Aug 2024
Lonza Prices EUR 1.2 Billion Dual-Tranche Straight Bonds
Basel, Switzerland, 28 August 2024 – Lonza Finance International NV, a wholly owned company of Lonza Group Ltd, Basel (“Lonza”), announced today the pricing of its dual tranche...
Corporate
25 Jul 2024
Lonza Nominates Juan Andres and Eric Drapé as Independent Board Members
Today, the Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to shareholders the election of both nominees at the Lonza Group Annual General Meeting (AGM) in May 202...
Corporate
25 Jul 2024
Lonza Group H1 2024 Performance Well On Track to Deliver Full-Year Outlook: Sales Up 1.8% CER and 29.2% CORE EBITDA Margin​
Lonza has reported sales of CHF 3.1 billion, growing 1.8% CER (-0.7% AER). CHF 893 million CORE EBITDA resulted in a robust margin of 29.2%, supported by favorable product mix and sustained demand for commercial CDMO services.
Corporate
01 Jul 2024
Lonza Welcomes New Group Chief Executive Officer Wolfgang Wienand
Wolfgang Wienand commences his tenure as Chief Executive Officer of Lonza Group Albert M. Baehny will retire from Lonza Group following a transition period Basel, Switzerland,...
Corporate
24 Jun 2024
Lonza to Enhance Governance with Updates to its Board Committee Structure
Today, the Lonza Board of Directors has announced a series of updates, which will take effect on 1 August 2024.
Corporate
14 May 2024
Q1 2024 Qualitative Update: Performance In Line with Expectations for Full-Year 2024
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s Softer performance in Q1 2024, normalizing across H1 2024 Sustained commercial demand in CDMO...
Corporate
08 May 2024
Lonza Announces Results of the 2024 Annual General Meeting – All Motions Proposed by Board of Directors Approved
Jean-Marc Huët was elected as Chairman of the Board of Directors  Shareholders re-elected all members of the Board of Directors standing for re-election A dividend of CHF 4.00...
1 2 3 4 ... 50 >
Media Advisories

Updates for media on the latest products, offerings and developments across our business.

View all